Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Connetics enters licensing and development agreement with Paladin for ConXn

July 12, 1999

Eisai in-licenses novel antiarthritic from Knoll

July 9, 1999

Valentis investigates multiple gene therapy approaches to treatment of arthritis

July 9, 1999

Ono synthesizes compounds that inhibit adhesion molecule expression

July 9, 1999

Cytokine production inhibitors in the pipeline at Sankyo

July 9, 1999

Teijin presents new series of chemokine antagonists

July 8, 1999

Potent, selective and orally bioavailable p38 MAP kinase inhibitor selected as development candidate

July 6, 1999

ZD-7349 may represent novel approach to allergic and autoimmune diseases

July 2, 1999

Novel antiinflammatory agent ML-3000 shows excellent gastroduodenal tolerability

July 1, 1999

Multifunctional antiinflammatory agents in development at ADIR

June 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...